ArticleThe Journal of clinical investigation2026
Second corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.
Yan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.